The role of romiplostim for pediatric patients with immune thrombocytopenia

The thrombopoietin receptor agonists (TPO-RAs) are a class of platelet growth factors used to treat immune thrombocytopenia (ITP) in children and adults. Romiplostim is a peptide TPO-RA approved for over a decade to treat adults with ITP but was just recently US Food and Drug Administration approved...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Samkari, Hanny, Grace, Rachael F., Kuter, David J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236573/
https://www.ncbi.nlm.nih.gov/pubmed/32523658
http://dx.doi.org/10.1177/2040620720912992

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236573/
https://www.ncbi.nlm.nih.gov/pubmed/32523658
http://dx.doi.org/10.1177/2040620720912992

Ejemplares similares